Medicine recalls
|
| |
| Canada: Zenhale (mometasone furoate/formoterol fumarate dihydrate inhalation aerosol) – recalled lots due to the possibility of device malfunction after 24 months shelf-life |
| |
Health Canada announced that Merck Canada was initiating a recall of Zenhale at the pharmacy/physician level due to the possibility of device malfunction of Zenhale after 24 months shelf-life, resulting in the potential for a patient to receive a lower dose than expected. The company’s investigation has determined that the occurrence of this defect is low. If a patient receives a lower dose of Zenhale than expected, they may experience increased asthma symptoms and worsening asthma control, including serious asthma exacerbation.
Details of the lot number involved can be found in the following website of Health Canada:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../43927a-eng.php
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Saturday, February 28, 2015
Issued at HKT 12:00
|
| |
